GE Healthcare Announces First Patient Dosed in Phase III Clinical Trial for New Dopamine Transporter Imaging Radiopharmaceutical
editor In full transparency, the following is a press release submitted to SOURCE media through its business wire service. *** MARLBOROUGH, – GE Healthcare has today, March 28. announced the first…